In conclusion, our study showed that PF, LBGF, CF, and L. fermentum CECT5716 can activate TLR9 in human P-IECs and reduce IL6 levels, what could have an anti-inflammatory effect in NEC and other bowel diseases (Fig. 7). Here, TLR9 is linked to necrotizing enterocolitis.